Abstract
This chapter aims to explain the range of congenital anomies that are encompassed by the term neural tube defects (NTD). Both cranial and spinal abnormalities occur which arise during embryological development due to defects in morphogenesis of the neural tube. They range from anencephaly to spina bifida occulta. The commonest congenital nervous system defect encountered remains spina bifida despite the overall incidence of neural tube defects declining. The chapter explains the classification, pathogenesis, assessment, management, treatment, and prognosis related to these conditions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adzick NS. Fetal surgery for spina bifida: past, present, future. Semin Pediatr Surg. 2013;22(1):10–7.
Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993–1004.
Aitken DA, Morrison NM, Ferguson-Smith MA. Predictive value of amniotic acetylcholinesterase analysis in the diagnosis of fetal abnormality in 3700 pregnancies. Prenat Diagn. 1984;4(5):329–40.
Van Allen MI. Multisite neural tube closure in humans. Birth Defects Orig Artic Ser. 1996;30(1):203–25.
Angerpointner TA, Pockrandt L, Schroer K. Course of pregnancy, family history and genetics in children with spina bifida. Z Kinderchir. 1990;45(2):72–7.
Asher M, Olson J. Factors affecting the ambulatory status of patients with spina bifida cystica. J Bone Joint Surg Am. 1983;65(3):350–6.
Atta CA, Fiest KM, Frolkis AD, et al. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am J Public Health. 2016;106(1):e24–34.
Barf HA, Verhoef M, Post MW, Jennekens-Schinkel A, Gooskens RH, Mullaart RA, et al. Educational career and predictors of type of education in young adults with spina bifida. Int J Rehabil Res. 2004;27(1):45–52.
Bayer C. Zur technik der operation der spina bifida and encephalocoele. Prag Med Wochenschr. 1892;17:317.
Bentley JF, Smith JR. Developmental posterior enteric remnants and spinal malformations: the split notochord syndrome. Arch Dis Child. 1960;35:76–86.
Bhide P, Sagoo GS, Moorthie S, et al. Systematic review of birth prevalence of neural tube defects in India. Birth Defects Res A Clin Mol Teratol. 2013;97(7):437–43.
Boone D, Parsons D, Lachmann SM, Sherwood T. Spina bifida occulta: lesion or anomaly? Clin Radiol. 1985;36(2):159–61.
Boulet SL, Yang Q, Mai C, Kirby RS, Collins JS, Robbins JM, et al. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol. 2008;82(7):527–32.
Bower C, D’Antoine H, Stanley FJ. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Birth Defects Res A Clin Mol Teratol. 2009;85(4):269–73.
Boyd PA, Devigan C, Khoshnood B, Loane M, Garne E, Dolk H. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndrome. BJOG. 2008;115(6):689–96.
Brown MS, Sheridan-Pereira M. Outlook for the child with a cephalocele. Pediatrics. 1992;90(6):914–9.
Bruinings AL, van den Berg-Emons HJ, Buffart LM, van der Heijden-Maessen HC, Roebroeck ME, Stam HJ. Energy cost and physical strain of daily activities in adolescents and young adults with myelomeningocele. Dev Med Child Neurol. 2007;49(9):672–7.
Bui CJ, Tubbs RS, Shannon CN, Acakpo-Satchivi L, Wellons JC, Blount JP, et al. Institutional experience with cranial vault encephaloceles. J Neurosurg. 2007;107(1 Suppl):22–5.
Caldarelli M, Di Rocco C, La Marca F. Shunt complications in the first postoperative year in children with myelomeningocoele. Childs Nerv Syst. 1996;12(12):748–54.
Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009;29(4):402–11.
Carter CO. Clues to the aetiology of neural tube malformations. Dev Med Child Neurol. 1974;16(6 Suppl 32):3–15.
Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1983;32(33):438–9. Valproate: a new cause of birth defects–report from Italy and follow-up from France.
Chadduck WM, Reding DL. Experience with simultaneous ventriculo-peritoneal shunt placement and myelomeningocele repair. J Pediatr Surg. 1988;23(10):913–6.
Charney EB. Parental attitudes toward management of newborns with myelomeningocele. Dev Med Child Neurol. 1990;32(1):14–9.
Charney EB, Weller SC, Sutton LN, Bruce DA, Schut LB. Management of the newborn with myelomeningocele: time for a decision-making process. Pediatrics. 1985;75(1):58–64.
Choux M, Di Rocco C, Hockley AD, Walker ML, editors. Pediatric neurosurgery. 1st ed. London: Churchill Livingstone; 1999. p. 875.
Copp AJ, Stanier P, De GN. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol. 2013;4422(13):1–12.
Copp AJ, Adzick NS, Chitty LS, et al. Spina bifida. Nat Rev Dis Primers. 2015;1:15007.
Date I, Yagyu Y, Asari S, Ohmoto T. Long-term outcome in surgically treated encephalocele. Surg Neurol. 1993;40(2):125–30.
Davis BE, Daley CM, Shurtleff DB, Duguay S, Seidel K, Loeser JD, et al. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg. 2005;41(4):186–91.
Dicianno BE, Karmarkar A, Houtrow A, et al. Factors associated with mobility outcomes in a National Spina Bifida Patient Registry. Am J Phys Med Rehabil. 2015;94(12):1015–25.
Doran PA, Guthkelch AN. Studies in spina bifida cystica I: general surgery and reassessment of the problem. J Neurol Neurosurg Psychiatry. 1961;24:331–45.
EUROCAT Working Group. Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980–1986. J Epidemiol Community Health. 1991;45(1):52–8.
Fitzgerald RJ, Healy B. The spina bifida problem: a longer term review with special reference to the quality of survival. Ir Med J. 1974;67(21):565–7.
Folate supplements prevent recurrence of neural tube defects. Nutr Rev. 1992;50:22–24. https://doi.org/10.1111/j.1753-4887.1992.tb02459.x.
Frazier CH. Surgery of the spine and spinal cord. New York: Appleton & Co.; 1918.
Fritsch MJ, Kienke S, Ankermann T, Padoin M, Mehdorn HM. Endoscopic third ventriculostomy in infants. J Neurosurg. 2005;56(6):1271–8.
Gardner WJ. Rupture of the neural tube. Arch Neurol. 1961;4:1–7.
Gorlin RJ, Cohen MM, Hennekam RCM. Syndromes of the head and neck. New York: Oxford University Press; 2001.
Greenberg M. Handbook of neurosurgery. 7th ed. New York: Thieme; 2010. p. 1352.
Greig JD, Young DG, Azmy AF. Follow-up of spina bifida children with and without upper renal tract changes at birth. Eur J Pediatr Surg. 1991;1(1):5–9.
Group MRCVSR. Prevention of neural tube defects: results of the Medical Research Council vitamin study MRC vitamin study research group. Lancet. 1991;338(8760):131–7.
Hunt GM. Open spina bifida: outcome for a complete cohort treated unselectively and followed into adulthood. Dev Med Child Neurol. 1990;32(2):108–18.
Hunt GM, Oakeshott P. Outcome in people with open spina bifida at age 35: prospective community based cohort study. BMJ. 2003;326(7403):1365–6.
Isada NB, Qureshi F, Jacques SM, Holzgreve W, Tout MJ, Johnson MP, et al. Meroanencephaly: pathology and prenatal diagnosis. Fetal Diagn Ther. 1993;8(6):423–8.
Janerich DT. Influenza and neural-tube defects. Lancet. 1971;2(7723):551–2.
Jenkinson MD, Campbell S, Hayhurst C, Clark S, Kandasamy J, Lee MK, et al. Cognitive and functional outcome in spina bifida-Chiari II malformation. Childs Nerv Syst. 2011;27(6):967–74.
Jenkinson MD, Hayhurst C, Al-Jumaily M, Kandasamy J, Clark S, Mallucci CL. The role of endoscopic third ventriculostomy in adult patients with hydrocephalus. J Neurosurg. 2009;110(5):861–6.
Jenkinson MD, Hayhurst C, Clark S, Campbell S, Murphy P, Mallucci CL. Long-term functional and neuropsychological outcome in Chiari II malformation. Childs Nerv Syst. 2008;24(10):1270.
Johnson MP, Bennett KA, Rand L, et al. Management of myelomeningocele study investigators. The management of myelomeningocele study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. Am J Obstet Gynecol. 2016;215(6):778.e1–9.
Joyeux L, Danzer E, Flake AW, et al. Fetal surgery for spina bifida aperta. Arch Dis Child Fetal Neonatal Ed. 2018;103(6):F589–F595.
Kasabian NG, Bauer SB, Dyro FM, Colodny AH, Mandell J, Retik AB. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child. 1992;146(7):840–3.
Kondo A, Kamihira O, Ozawa H. Neural tube defects: prevalence, etiology and prevention. Int J Urol. 2009;16(1):49–57.
Kooper AJ, de Bruijn D, van Ravenwaaij-Arts CM, Faas BH, Creemers JW, Thomas CM, et al. Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects. Prenat Diagn. 2007;27(1):29–33.
Larsen W. Human Embryology. 1st ed. New York: Churchill Livingstone; 1993. p. 479.
Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed). 1981;282(6275):1509–11.
Layde PM, Edmonds LD, Erickson JD. Maternal fever and neural tube defects. Teratology. 1980;21(1):105–8.
Leck I. The etiology of human malformations: insights from epidemiology. Teratology. 1972;5(3):303–14.
Leck I. The geographical distribution of neural tube defects and oral clefts. Br Med Bull. 1984;40(4):390–5.
Lemire RJ, Beckwith JB, Warkny J. Anencephaly. New York: Raven Press; 1978.
Li Z, Ren A, Zhang L, et al. A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China. Paediatr Perinat Epidemiol. 2006;20(1):45–53.
Lindhout D, Omtzigt JG, Cornel MC. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology. 1992;42(4 Suppl 5):111–8.
Van Lith JMM, Johnson MP, Wilson RD. Current controversies in prenatal diagnosis 3: fetal surgery after MOMS: is fetal therapy better than neonatal? Prenat Diagn. 2013;33(1):13–6.
Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Dev Med Child Neurol. 1971;13(3):279–303.
Lorber J, Salfield SA. Results of selective treatment of spina bifida cystica. Arch Dis Child. 1981;56(11):822–30.
Luthy DA, Wardinsky T, Shurtleff DB, Hollenbach KA, Hickok DE, Nyberg DA, et al. Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally. N Engl J Med. 1991;324(10):662–6.
McCarthy GT. Treating children with spina bifida. BMJ. 1991;302(6768):65–6.
McConnell JR, Holder JC, Menick JR, Alexander JE. The radiology of neural tube defects. Curr Probl Diagn Radiol. 1986;15(4):244–76.
Milunsky A, Jick SS, Bruell CL, MacLaughlin DS, Tsung YK, Jick H, et al. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol. 1989;161(2):291–7.
Milunsky A, Ulcickas M, Rothman KJ, Willett W, Jick SS, Jick H. Maternal heat exposure and neural tube defects. JAMA. 1992;268(7):882–5.
Moore K, Persaud T, Torchia M. The developing human. 9th ed. Saint Louis: Elsevier; 2011. p. 562.
Morgagni JB. Je sedibus et causis morborum per indagatis. Naples: Typographia Simoniana; 1762. p. 1962.
Morton J. Case of spina bifida cured by injection. Br Med J. 1872;1:364.
O’Brien DF, Javadpour M, Collins DR, Spennato P, Mallucci CL. Endoscopic third ventriculostomy: an outcome analysis of primary cases and procedures performed after ventriculoperitoneal shunt malfunction. J Neurosurg. 2005;103(5 Suppl):393–400.
Oakeshott P, Hunt GM. Long-term outcome in open spina bifida. Br J Gen Pract. 2003;53(493):632–6.
Oakeshott P, Hunt GM, Poulton A, Reid F. Open spina bifida: birth findings predict long-term outcome. Arch Dis Child. 2012;97(5):474–6.
Obladen M. Cats, frogs, and snakes: early concepts of neural tube defects. J Child Neurol. 2011;26(11):1452–61.
Olney RS, Mulinare J. Trends in neural tube defect prevalence, folic acid fortification, and vitamin supplement use. Semin Perinatol. 2002;26(4):277–85.
Pang D. Surgical complications of open spinal dysraphism. Neurosurg Clin N Am. 1995;6(2):243–57.
Parent AD, McMillan T. Contemporaneous shunting with repair of myelomeningocele. Pediatr Neurosurg. 1995;22(3):132–5. discussion 136
Parker SE, Yazdy MM, Tinker SC, Mitchell AA, Werler MM. The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am J Obstet Gynecol. 2013;209(3):239.e1–8.
Patten BM. Overgrowth of the neural tube in young human embryos. Anat Rec. 1952;113(4):381–93.
Pollack IF, Pang D, Albright AL, Krieger D. Outcome following hindbrain decompression of symptomatic Chiari malformations in children previously treated with myelomeningocele closure and shunts. J Neurosurg. 1992;77(6):881–8.
Report of a committee of the society nominated to investigate spina bifida. Trans Chir Soc. London; 1882 p. 339.
Rickwood AMK. Infective problems encountered in neonatal closure of the neural tube defects. Dev Med Child Neurol. 1976;18:164–5.
Robards MF, Thomas GG, Rosenbloom L. Survival of infants with unoperated myeloceles. Br Med J. 1975;4(5987):12–3.
Romero R, Mathisen JM, Ghidini A, Sirtori M, Hobbins JC. Accuracy of ultrasound in the prenatal diagnosis of spinal anomalies. Am J Perinatol. 1989;6(3):320–3.
Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med. 1991;324(10):674–7.
Rudy DC, Woodside JR. The incontinent myelodysplastic patient. Urol Clin North Am. 1991;18(2):295–308.
Sadler TW. Embryology of neural tube development. Am J Med Genet C Semin Med Genet. 2005;135C(1):2–8.
Sakala EP, Andree I. Optimal route of delivery for meningomyelocele. Obstet Gynecol Surv. 1990;45(4):209–12.
Sandford MK, Kissling GE, Joubert PE. Neural tube defect etiology: new evidence concerning maternal hyperthermia, health and diet. Dev Med Child Neurol. 1992;34(8):661–75.
Seitzberg A, Lind M, Biering-Sorensen F. Ambulation in adults with myelomeningocele. Is it possible to predict the level of ambulation in early life? Childs Nerv Syst. 2008;24(2):231–7.
Sharrard WJ, Zachary RB, Lorber J. Survival and paralysis in open myelomeningocele with special reference to the time of repair of the spinal lesion. Dev Med Child Neurol. 1967;Suppl 13:35–50.
Smithells RW, Chinn ER. Spina bifida in Liverpool. Dev Med Child Neurol. 1965;7:258–68.
Snow-Lisy DC, Yerkes EB, Cheng EY. Update on urological management of spina bifida from prenatal diagnosis to adulthood. J Urol. 2015;194(2):288–96.
Stein SC, Schut L. Hydrocephalus in myelomeningocele. Childs Brain. 1979;5(4):413–9.
Stevenson KL. Chiari type II malformation: past, present, and future. Neurosurg Focus. 2004;16(2):E5.
Stevenson RE, Allen WP, Pai GS, Best R, Seaver LH, Dean J, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics. 2000;106(4):677–83.
Stoneking BJ, Brock JW, Pope JC, Adams MC. Early evolution of bladder emptying after myelomeningocele closure. Urology. 2001;58(5):767–71.
Surana RH, Quinn FM, Guiney EJ, Fitzgerald RJ. Are the selection criteria for the conservative management in spina bifida still applicable? Eur J Pediatr Surg. 1991;1(Suppl 1):35–7.
Sutton LN. Fetal surgery for neural tube defects. Best Pract Res Clin Obstet Gynaecol. 2008;22(1):175–88.
Suwanwela C, Suwanwela N. A morphological classification of sincipital encephalomeningoceles. J Neurosurg. 1972;36(2):201–11.
Takeuchi H. Prenatal ultrasound diagnosis of central nervous system anomalies. No To Hattatsu. 1991;23(2):183–8.
Thompson DN. Postnatal management and outcome for neural tube defects including spina bifida and encephalocoeles. Prenat Diagn. 2009;29(4):412–9.
Tuli S, Drake J, Lamberti-Pasculli M. Long-term outcome of hydrocephalus management in myelomeningoceles. Childs Nerv Syst. 2003;19(5–6):286–91.
Tulp N. Observationes medicae. Amsterdam: Elsevier; 1672.
Vachha B, Adams RC, Rollins NK. Limbic tract anomalies in pediatric myelomeningocele and Chiari II malformation: anatomic correlations with memory and learning: initial investigation. Radiology. 2006;240(1):194–202.
Valproate: a new cause of birth defects—report from Italy and follow-up from France. MMWR Morb Mortal Wkly Rep. 1983;32(33):438–9.
Valproate, spina bifida, and birth defect registries. Lancet. 1988;332(8625):1404–5.
Valtonen K, Karlsson A-K, Alaranta H, Viikari-Juntura E. Work participation among persons with traumatic spinal cord injury and meningomyelocele. J Rehabil Med. 2006;38(3):192–200.
Vandertop WP, Asai A, Hoffman HJ, Drake JM, Humphreys RP, Rutka JT, et al. Surgical decompression for symptomatic Chiari II malformation in neonates with myelomeningocele. J Neurosurg. 1992;77(4):541–4.
Vinck A, Maassen B, Mullaart R, Rotteveel J. Arnold-Chiari-II malformation and cognitive functioning in spina bifida. J Neurol Neurosurg Psychiatry. 2006;77(9):1083–6.
Virchow R. Ein fall von hypertrichosis circumscripta mediana kornbiniert mit spina bifida. Ztschaz Ethnol. 1875;7:279.
Wald NJ, Bower C. Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet. 1994;343(8893):307.
Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE, Woodford FP. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet. 1977;1(8026):1323–32.
De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135–42.
White-Van Mourik MC, Connor JM, Ferguson-Smith MA. Patient care before and after termination of pregnancy for neural tube defects. Prenat Diagn. 1990;10(8):497–505.
Willett WC. Folic acid and neural tube defect: can’t we come to closure? Am J Public Health. 1992;82(5):666–8.
Wiswell TE, Tuttle DJ, Northam RS, Simonds GR. Major congenital neurologic malformations: a 17-year survey. Am J Dis Child. 1990;144(1):61–7.
Woodhouse CR. Myelomeningocele: neglected aspects. Pediatr Nephrol. 2008;23(8):1223–31.
Yen IH, Khoury MJ, Erickson JD, James LM, Waters GD, Berry RJ. The changing epidemiology of neural tube defects. United States, 1968–1989. Am J Dis Child. 1992;146(7):857–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Ellenbogen, J.R., Jenkinson, M.D., Mallucci, C.L. (2020). Spina Bifida and Encephalocele. In: Puri, P. (eds) Pediatric Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43588-5_87
Download citation
DOI: https://doi.org/10.1007/978-3-662-43588-5_87
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43587-8
Online ISBN: 978-3-662-43588-5
eBook Packages: MedicineReference Module Medicine